NMN for Glaucoma: What the Evidence Actually Shows
What is Glaucoma?
Glaucoma is a group of eye diseases that damage the optic nerve, often associated with raised intraocular pressure. Untreated, it leads to irreversible vision loss.
NMN relevance: the published evidence
A widely-cited mouse study (Williams 2017) showed nicotinamide protected retinal ganglion cells in a glaucoma model. Small human pilot trials of high-dose nicotinamide in glaucoma showed visual function gains. NMN itself has not been tested in glaucoma, and pressure-lowering drops or surgery remain standard.
Questions to ask before supplementing
No NMN dose validated; nicotinamide pilot used 1.5-3 g/day (different molecule).
Contraindications and red flags
Never replace prescribed glaucoma drops with supplements.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have glaucoma, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Age-Related Macular Degeneration - Age-related macular degeneration is the leading cause of central vision loss in older adults. It exi...
- Dry Eye Disease - Dry eye disease is a chronic problem of tear film instability, causing irritation, blurred vision an...
- Biological Aging - Biological aging refers to the gradual decline in cellular and organ function that accompanies chron...
- Age-Related Cognitive Decline - Age-related cognitive decline is the gradual slowing of processing speed, memory and executive funct...